Home LiteratureArticle Details
PMID: 8879197 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands.

The Journal of experimental medicine ·Vol. 184 ·No. 4 ·1996-10-01 ·Pages 1259-68

Kersh GJ, Allen PM

Abstract

T cells recognize short linear peptides bound to major histocompatibility complex (MHC)-encoded molecules. Subtle molecular changes in peptide antigens produce altered peptide ligands (APLs), which induce different T cell responses from those induced by the antigenic ligand. A molecular basis for how these slight molecular variations lead to such different consequences for the T cell has not been described. To address this issue, we have made amino acid substitutions at the primary T cell receptor (TCR) contact residue of the murine hemoglobin determinant, Hb(64-76)/I-Ek and produced 12 peptides that interact with the TCR of the T cell clone 3.L2. The 3.L2 T cell responds to these peptides, which vary 1 million-fold in their activity, and enables them to be ranked according to their relative ability to signal through the 3.L2 TCR. Such a ranking reveals that the ability of the 3.L2 T cell to respond to these peptides depends on how well the structure of the side chain at the primary TCR contact site mimics that of the Asn residue present in the antigenic ligand. The reactivity of the 3.L2 T cell also depends on an MHC contact residue that is next to the primary TCR contact residue, suggesting that conformation of the Asn side chain is also important. By using nonnatural amino acids at a TCR contact residue, we have demonstrated that APLs can be rationally designed based on structure. These data are consistent with a model in which the affinity of a peptide-MHC complex for the TCR determines how the T cell will respond.

MeSH Terms
Animals Apoptosis Clone Cells/metabolism Epitopes/metabolism Hemoglobins/chemistry,metabolism Histocompatibility Antigens/genetics,metabolism Hybridomas/metabolism Ligands Major Histocompatibility Complex/genetics Mice Oligopeptides/metabolism Peptide Fragments/chemistry,metabolism Protein Binding Receptors, Antigen, T-Cell/agonists,antagonists & inhibitors,metabolism Structure-Activity Relationship T-Lymphocytes/metabolism
Chemicals
Epitopes Hemoglobins Histocompatibility Antigens Ligands Oligopeptides Peptide Fragments Receptors, Antigen, T-Cell hemoglobin (64-76)
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kersh G J
Center for Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Allen P M
References (37)
37 references, click to expand
  1. Antimetabolites produced by microorganisms. II. L-2-amino-4-pentynoic acid.
    J Antibiot (Tokyo). 1971 Apr;24(4):239-44 PMID: 4995438
  2. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists.
    Immunity. 1996 Jul;5(1):53-61 PMID: 8758894
  3. Binding of antigen in the absence of histocompatibility proteins by arsonate-reactive T-cell clones.
    Cell. 1984 Apr;36(4):879-88 PMID: 6608410
  4. Analogs that compete for antigen binding to an arsonate-reactive T-cell clone inhibit the functional response to arsonate.
    Cell. 1984 Apr;36(4):889-95 PMID: 6423288
  5. Binding of immunogenic peptides to Ia histocompatibility molecules.
    Nature. 1985 Sep 26-Oct 2;317(6035):359-61 PMID: 3876513
  6. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
    Cell. 1986 Mar 28;44(6):959-68 PMID: 2420472
  7. Structure of the human class I histocompatibility antigen, HLA-A2.
    Nature. 1987 Oct 8-14;329(6139):506-12 PMID: 3309677
  8. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.
    Nature. 1987 Oct 8-14;329(6139):512-8 PMID: 2443855
  9. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.
    Science. 1991 May 31;252(5010):1308-10 PMID: 1833816
  10. Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas.
    J Immunol. 1992 Jan 15;148(2):347-53 PMID: 1370311
  11. Low affinity interaction of peptide-MHC complexes with T cell receptors.
    Science. 1991 Dec 20;254(5039):1788-91 PMID: 1763329
  12. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor.
    Cell. 1992 Feb 21;68(4):625-34 PMID: 1739971
  13. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.
    Science. 1992 Aug 14;257(5072):919-27 PMID: 1323877
  14. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides.
    J Immunol. 1993 Apr 15;150(8 Pt 1):3131-40 PMID: 8468461
  15. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells.
    Nature. 1993 May 13;363(6425):156-9 PMID: 8483498
  16. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells.
    J Exp Med. 1993 Jun 1;177(6):1541-50 PMID: 8496675
  17. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
    Nature. 1993 Jul 1;364(6432):33-9 PMID: 8316295
  18. T cell receptor antagonist peptides induce positive selection.
    Cell. 1994 Jan 14;76(1):17-27 PMID: 8287475
  19. Peptides in positive and negative selection: a delicate balance.
    Cell. 1994 Feb 25;76(4):593-6 PMID: 8124703
  20. Evidence for a differential avidity model of T cell selection in the thymus.
    Cell. 1994 Feb 25;76(4):651-63 PMID: 8124708
  21. Positive and negative thymocyte selection induced by different concentrations of a single peptide.
    Science. 1994 Mar 18;263(5153):1615-8 PMID: 8128249
  22. Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand.
    Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2300-4 PMID: 8134391
  23. Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists.
    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4057-61 PMID: 7909610
  24. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.
    Nature. 1994 Jun 2;369(6479):403-7 PMID: 7515165
  25. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells.
    Nature. 1994 Jun 2;369(6479):407-10 PMID: 8196768
  26. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.
    Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12862-6 PMID: 7809136
  27. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo.
    J Exp Med. 1995 Apr 1;181(4):1569-74 PMID: 7699337
  28. Kinetic proofreading in T-cell receptor signal transduction.
    Proc Natl Acad Sci U S A. 1995 May 23;92(11):5042-6 PMID: 7761445
  29. Ligands for the T-cell receptor: hard times for avidity models.
    Immunol Today. 1995 May;16(5):223-5 PMID: 7779252
  30. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands.
    Immunity. 1995 Jun;2(6):655-63 PMID: 7540944
  31. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis.
    Immunity. 1995 Oct;3(4):397-405 PMID: 7584131
  32. Essential flexibility in the T-cell recognition of antigen.
    Nature. 1996 Apr 11;380(6574):495-8 PMID: 8606766
  33. Kinetic discrimination in T-cell activation.
    Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1401-5 PMID: 8643643
  34. T-cell-receptor affinity and thymocyte positive selection.
    Nature. 1996 Jun 13;381(6583):616-20 PMID: 8637599
  35. Endogenous altered peptide ligands can affect peripheral T cell responses.
    J Exp Med. 1996 Apr 1;183(4):1311-21 PMID: 8666889
  36. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology.
    Annu Rev Immunol. 1996;14:1-27 PMID: 8717505
  37. Tolerance as an active process.
    Nature. 1980 Nov 27;288(5789):385-7 PMID: 6159554
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1996-10-01
Pages
1259-68
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2192852
Subset
IM
Grants
NIAID NIH HHS · AI-24157 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com